Search Results - "Hatami, Behzad"

Refine Results
  1. 1

    Antimicrobial Resistance as a Hidden Menace Lurking Behind the COVID-19 Outbreak: The Global Impacts of Too Much Hygiene on AMR by Rezasoltani, Sama, Yadegar, Abbas, Hatami, Behzad, Asadzadeh Aghdaei, Hamid, Zali, Mohammad Reza

    Published in Frontiers in microbiology (15-12-2020)
    “…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus that was recently discovered in 2019. While the world is working hard to…”
    Get full text
    Journal Article
  2. 2

    Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial by Saadati, Saeede, Sadeghi, Amir, Mansour, Asieh, Yari, Zahra, Poustchi, Hossein, Hedayati, Mehdi, Hatami, Behzad, Hekmatdoost, Azita

    Published in BMC gastroenterology (25-07-2019)
    “…The aim of the present study was to evaluate the effects of curcumin supplementation on inflammatory indices, and hepatic features in patients with…”
    Get full text
    Journal Article
  3. 3

    Obeticholic acid-loaded exosomes attenuate liver fibrosis through dual targeting of the FXR signaling pathway and ECM remodeling by Azizsoltani, Arezou, Hatami, Behzad, Zali, Mohammad Reza, Mahdavi, Vahideh, Baghaei, Kaveh, Alizadeh, Effat

    Published in Biomedicine & pharmacotherapy (01-12-2023)
    “…End-stage of liver fibrosis as a precancerous state could lead to cirrhosis and hepatocellular carcinoma which liver transplantation is the only effective…”
    Get full text
    Journal Article
  4. 4

    The association of dietary inflammatory indices and mortality in patients with cirrhosis: a cohort based study by Khodadadi, Navideh, Hekmatdoost, Azita, Pashayee-Khamene, Fereshteh, Karimi, Sara, Ahmadzadeh, Saleheh, Saberifiroozi, Mehdi, Hatami, Behzad, Yari, Zahra

    Published in Scientific reports (14-09-2024)
    “…Dietary intake has an undeniable role in the development and progression as well as the prevention and treatment of cirrhosis. This study was conducted with…”
    Get full text
    Journal Article
  5. 5

    Dietary acid load and cirrhosis-related mortality: a prospective cohort study by Pashayee-Khamene, Fereshteh, Heidari, Zeinab, Fotros, Danial, Hekmatdoost, Azita, Karimi, Sara, Ahmadzadeh, Saleheh, Saberifiroozi, Mehdi, Hatami, Behzad, Yari, Zahra

    Published in Scientific reports (14-02-2024)
    “…As a global health concern, cirrhosis contributes significantly to morbidity and mortality. This prospective cohort study aimed to investigate the association…”
    Get full text
    Journal Article
  6. 6

    The effect of soy isoflavones supplementation on metabolic status in patients with non-alcoholic fatty liver disease: a randomized placebo controlled clinical trial by Neshatbini Tehrani, Asal, Hatami, Behzad, Daftari, Ghazal, Hekmatdoost, Azita, Yari, Zahra, Salehpour, Amin, Hosseini, Seyed Ahmad, Helli, Bizhan

    Published in BMC public health (21-05-2024)
    “…Non-alcoholic fatty liver disease (NAFLD) accounts as a crucial health concern with a huge burden on health and economic systems. The aim of this study is to…”
    Get full text
    Journal Article
  7. 7

    The association between plant-based diet indices and risk of mortality in patients with cirrhosis: a cohort study by Tabar, Mohsen Shaygan, Fotros, Danial, Hekmatdoost, Azita, Pashayee-Khamene, Fereshteh, Karimi, Sara, Ahmadzadeh, Saleheh, Saberifiroozi, Mehdi, Hatami, Behzad, Yari, Zahra

    Published in BMC gastroenterology (07-11-2024)
    “…Background Following a plant-based diet is associated with a wide range of health benefits. The current study aimed to investigate the association between…”
    Get full text
    Journal Article
  8. 8

    The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A by Neshatbini Tehrani, Asal, Hatami, Behzad, Helli, Bizhan, Yari, Zahra, Daftari, Ghazal, Salehpour, Amin, Hedayati, Mehdi, Khalili, Elmira, Hosseini, Seyed Ahmad, Hekmatdoost, Azita

    Published in Scientific reports (01-03-2024)
    “…A two-arm randomized open labeled controlled clinical trial was conducted on 50 patients with non-alcoholic fatty liver disease (NAFLD). Subjects were…”
    Get full text
    Journal Article
  9. 9

    Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches by Mahmoudi, Seyedeh Kosar, Tarzemani, Shadi, Aghajanzadeh, Taha, Kasravi, Mohammadreza, Hatami, Behzad, Zali, Mohammad Reza, Baghaei, Kaveh

    Published in European journal of medical research (20-03-2024)
    “…Non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver diseases, affecting more than one-quarter of people worldwide. Hepatic…”
    Get full text
    Journal Article
  10. 10

    Dietary Approaches to Stop Hypertension (DASH) and mortality risk among patients with liver cirrhosis: a prospective cohort study by Zarei, Aida, Pashayee-Khamene, Fereshteh, Hekmatdoost, Azita, Karimi, Sara, Ahmadzadeh, Saleheh, Saberifiroozi, Mehdi, Hatami, Behzad, Yari, Zahra

    Published in BMC research notes (04-09-2024)
    “…The relationship between dietary patterns and cirrhosis is undeniable. The present study aimed to investigate the association between the Dietary Approaches to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Atypical presentation of autoimmune hepatitis–primary sclerosing cholangitis overlap syndrome associated with hypereosinophilia: a case report and review of the literature by Hatami, Behzad, Rahmani Seraji, Hamide, fallahi, Mohaddese

    Published in Journal of medical case reports (19-10-2021)
    “…Abstract Background Autoimmune hepatitis–primary sclerosing cholangitis overlap syndrome is a form of autoimmune hepatitis with cholestatic features and is…”
    Get full text
    Journal Article
  13. 13

    Fibroblast growth factor 2 reduces endoplasmic reticulum stress and apoptosis in in-vitro Non-Alcoholic Fatty Liver Disease model by Hosseini, Seyedeh Parisa, Farivar, Shirin, Rezaei, Ramazan, Tokhanbigli, Samaneh, Hatami, Behzad, Zali, Mohammad Reza, Baghaei, Kaveh

    Published in Daru (09-05-2023)
    “…Purpose Non-Alcoholic fatty liver disease is characterized by the accumulation of excess fat in the liver, chronic inflammation, and cell death, ranging from…”
    Get full text
    Journal Article
  14. 14

    Dietary protein intake and mortality among survivors of liver cirrhosis: a prospective cohort study by Daftari, Ghazal, Tehrani, Asal Neshatbini, Pashayee-Khamene, Fereshteh, Karimi, Sara, Ahmadzadeh, Saleheh, Hekmatdoost, Azita, Salehpour, Amin, Saber-Firoozi, Mahdi, Hatami, Behzad, Yari, Zahra

    Published in BMC gastroenterology (03-07-2023)
    “…Liver cirrhosis is a worldwide burden and is associated with poor clinical outcomes, including increased mortality. The beneficial effects of dietary…”
    Get full text
    Journal Article
  15. 15

    Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies by Lotfinia, Majid, Abdollahpour-Alitappeh, Meghdad, Hatami, Behzad, Zali, Mohammad Reza, Karimipoor, Morteza

    Published in Clinical and experimental medicine (01-08-2019)
    “…Adeno-associated virus (AAV)-derived vectors are currently the most common type of viral vectors used in gene therapy clinical trials. The presence of…”
    Get full text
    Journal Article
  16. 16

    Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis by Aghajanzadeh, Taha, Talkhabi, Mahmood, Zali, Mohammad Reza, Hatami, Behzad, Baghaei, Kaveh

    Published in Non-coding RNA research (01-12-2023)
    “…Liver fibrosis is the excessive accumulation of extracellular matrix proteins. Due to the lack of an accurate test for an early diagnosis of liver fibrosis and…”
    Get full text
    Journal Article
  17. 17

    Dietary total antioxidant capacity in relation to disease severity and risk of mortality in cirrhosis; results from a cohort study by Pashayee-Khamene, Fereshteh, Hajimohammadebrahim-Ketabforoush, Melika, Heidari, Zeinab, Yari, Zahra, Karimi, Sara, Saber-firoozi, Mahdi, Hatami, Behzad, Hekmatdoost, Azita

    Published in Heliyon (30-09-2024)
    “…Liver Cirrhosis, defined as the final stage of chronic liver disease, may become more prevalent in the lower level of body defense against oxidation and…”
    Get full text
    Journal Article
  18. 18

    Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial by Hatami, Behzad, Mosala, Mozhde, Hassani, Amir Hossein, Ardakani, Mohammad Javad Ehsani, Gholami, Samira, Zali, Mohammad Reza

    Published in Pharmacology research & perspectives (01-08-2022)
    “…Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with no medical treatment proven to improve survival and postpone liver…”
    Get full text
    Journal Article
  19. 19

    How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19? by Rezasoltani, Sama, Hatami, Behzad, Yadegar, Abbas, Asadzadeh Aghdaei, Hamid, Zali, Mohammad Reza

    Published in Frontiers in medicine (10-07-2020)
    “…The human pathogenic coronaviruses cause infections of the respiratory tract from mild to severe ranges. Mild cases may look like the common cold, while cases…”
    Get full text
    Journal Article
  20. 20

    Salt consumption and mortality risk in cirrhotic patients: results from a cohort study by Pashayee-Khamene, Fereshteh, Hajimohammadebrahim-Ketabforoush, Melika, Saber-Firoozi, Mahdi, Hatami, Behzad, Naseri, Kaveh, Karimi, Sara, Ahmadzadeh, Saleheh, Kord, Hamed, Saadati, Saeede, Hekmatdoost, Azita

    “…Since conducting a long-term randomised clinical trial is not logical and feasible to find the optimum dosage of salt intake in patients with cirrhosis, cohort…”
    Get full text
    Journal Article